Obesity has been a persistent public health concern in the U.S. and globally, with 1 in every 8 people in the world living ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

"Americans are fat and getting fatter," wrote Reason's Ron Bailey in a March 2023 piece about obesity and the hope such ...

Consumption of UPFs increased body weight and energy intake in overweight and obese young men, found a small study ...

Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as ...

At least 1 in 5 adults in each U.S. state live with obesity, new data from the Centers for Disease Control and Prevention ...

Eli Lilly shares rose as concerns about a shortage of its obesity drug continued to ease. About 6.8 million people are taking branded drugs of the glucose-like peptide inhibitor class with about ...

Researchers raise concerns in a recent commentary. Since 1990, the prevalence of childhood overweight and obesity has nearly ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

Readers discuss an essay about whether it is a disease and how it should be diagnosed. Also: Fear in schools; natural ...

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...

Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout ...